Structural Mapping of Adenosine Receptor Mutations: Ligand Binding and Signaling Mechanisms
Research output: Contribution to journal › Review › Research › peer-review
Standard
Structural Mapping of Adenosine Receptor Mutations : Ligand Binding and Signaling Mechanisms. / Jespers, Willem; Schiedel, Anke C; Heitman, Laura H; Cooke, Robert M; Kleene, Lisa; van Westen, Gerard J P; Gloriam, David E; Müller, Christa E; Sotelo, Eddy; Gutiérrez-de-Terán, Hugo.
In: Trends in Pharmacological Sciences, Vol. 39, No. 1, 01.2018, p. 75-89.Research output: Contribution to journal › Review › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Structural Mapping of Adenosine Receptor Mutations
T2 - Ligand Binding and Signaling Mechanisms
AU - Jespers, Willem
AU - Schiedel, Anke C
AU - Heitman, Laura H
AU - Cooke, Robert M
AU - Kleene, Lisa
AU - van Westen, Gerard J P
AU - Gloriam, David E
AU - Müller, Christa E
AU - Sotelo, Eddy
AU - Gutiérrez-de-Terán, Hugo
N1 - Copyright © 2017 Elsevier Ltd. All rights reserved.
PY - 2018/1
Y1 - 2018/1
N2 - The four adenosine receptors (ARs), A1, A2A, A2B, and A3, constitute a subfamily of G protein-coupled receptors (GPCRs) with exceptional foundations for structure-based ligand design. The vast amount of mutagenesis data, accumulated in the literature since the 1990s, has been recently supplemented with structural information, currently consisting of several inactive and active structures of the A2A and inactive conformations of the A1 ARs. We provide the first integrated view of the pharmacological, biochemical, and structural data available for this receptor family, by mapping onto the relevant crystal structures all site-directed mutagenesis data, curated and deposited at the GPCR database (available through http://www.gpcrdb.org). This analysis provides novel insights into ligand binding, allosteric modulation, and signaling of the AR family.
AB - The four adenosine receptors (ARs), A1, A2A, A2B, and A3, constitute a subfamily of G protein-coupled receptors (GPCRs) with exceptional foundations for structure-based ligand design. The vast amount of mutagenesis data, accumulated in the literature since the 1990s, has been recently supplemented with structural information, currently consisting of several inactive and active structures of the A2A and inactive conformations of the A1 ARs. We provide the first integrated view of the pharmacological, biochemical, and structural data available for this receptor family, by mapping onto the relevant crystal structures all site-directed mutagenesis data, curated and deposited at the GPCR database (available through http://www.gpcrdb.org). This analysis provides novel insights into ligand binding, allosteric modulation, and signaling of the AR family.
KW - Journal Article
KW - Review
U2 - 10.1016/j.tips.2017.11.001
DO - 10.1016/j.tips.2017.11.001
M3 - Review
C2 - 29203139
VL - 39
SP - 75
EP - 89
JO - Trends in Pharmacological Sciences
JF - Trends in Pharmacological Sciences
SN - 0165-6147
IS - 1
ER -
ID: 186867144